| Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394) |
|---|
| 09/29/2005 | US20050215490 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent |
| 09/28/2005 | EP1578898A2 Nad synthetase inhibitors and uses thereof |
| 09/21/2005 | EP1575912A1 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 09/21/2005 | EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists |
| 09/20/2005 | US6946576 amidation; reacting an amine and an ester in the presence of a silylating agent as catalyst under mild conditions |
| 09/15/2005 | WO2005085159A1 Inositol-based molecular transporters and processes for the preparation thereof |
| 09/15/2005 | US20050203170 Chalcones substitued with amine or amino acid-derived amide, specifically (S)-2-amino-3-hydroxypropanoic acid (2-methoxy-5-[2-methyl-3-oxo-3-(3,4,5-trimethoxyphenyl)propenyl]phenyl)amide hydrochloride; use inhibiting tubulin polymerization; antitumor agents |
| 09/14/2005 | CN1666980A L-chelated calcium arginine |
| 09/14/2005 | CN1666977A L-chelated magnesium arginine |
| 09/14/2005 | CN1666976A L-chelated zinc arginine |
| 09/13/2005 | US6943269 Contrast media for angiography |
| 09/01/2005 | WO2005080322A1 Fluorene derivative |
| 09/01/2005 | CA2537079A1 Fluorene derivative |
| 08/31/2005 | EP1567484A1 Polyene polyketides, processes for their production and their use as pharmaceuticals |
| 08/30/2005 | US6936640 uses the strong antimicrobial properties of polymeric biguanides and the low cytotoxicity profile of polymeric quaternary ammonium compounds |
| 08/25/2005 | US20050187409 Inhibitors of RNase P proteins as antibacterial compounds |
| 08/25/2005 | US20050187167 Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 08/25/2005 | DE102004005404A1 Verfahren zur Herstellung von Guanidinium-Salzen A process for preparing guanidinium salts |
| 08/24/2005 | EP1565430A1 Biguanide and dihydrotriazine derivatives |
| 08/24/2005 | CN1659156A Novel guanidinobenzamides |
| 08/24/2005 | CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament |
| 08/23/2005 | CA2089442C Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 08/18/2005 | WO2005075414A1 Peptidyl arginine deiminase type iv inhibitor |
| 08/18/2005 | WO2005075413A1 Method for producing guanidinium salts |
| 08/18/2005 | US20050182057 Aryl N-cyanoguanidines and methods related thereto |
| 08/18/2005 | US20050182029 Metformin tocopherol phosphate gel; time-release agent; antihyperglycemic agent; improved gastrointestinal absorption |
| 08/18/2005 | US20050180932 Ultraviolet absorption compositions |
| 08/18/2005 | CA2555199A1 Peptidylarginine deiminase 4 inhibitor |
| 08/16/2005 | US6930106 Inhibitors of HCV NS5B polymerase |
| 08/11/2005 | WO2005072246A2 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof |
| 08/11/2005 | WO2005072121A2 Carrier ampholytes of high ph range |
| 08/11/2005 | US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors |
| 08/11/2005 | US20050176653 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent |
| 08/11/2005 | US20050175543 Agents for magnetic imaging method |
| 08/11/2005 | CA2554163A1 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof |
| 08/10/2005 | EP1324760A4 Creatine ester pronutrient compounds and formulations |
| 08/10/2005 | CN1653037A Substituted tetracycline compounds |
| 08/09/2005 | US6927218 Aryl N-cyanoguanidines and methods related thereto |
| 08/09/2005 | CA2258217C Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 08/09/2005 | CA2162920C Process for the production of aminoalkylguanidines |
| 08/03/2005 | EP1559718A1 Combretastatin A-4 phosphate prodrug salts with nitrogen-containing compounds |
| 08/03/2005 | EP1087948B1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators |
| 08/03/2005 | CN1213035C 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators |
| 07/28/2005 | WO2005068488A1 Method for synthesising peptidic compounds, in particular arginine residues-containing peptidic compounds on a solid support |
| 07/28/2005 | WO2005051296A3 Fused ring dicationic anti-protozoan agents and their prodrugs |
| 07/28/2005 | US20050165102 Improved bioavailability by complexing a drug such as metformin with an ionic moiety such as a fatty acid; e.g. metformin laurate; wrong claims attached to this publication |
| 07/28/2005 | US20050165044 Use against Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum; prodrugs of these compounds can be used as oral treatment for malaria and human African trypanosomiasis; 2,7-bis-guanidino-9H-fluorene, 2,7-bis-guanidinofluoren-9-one |
| 07/28/2005 | US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050163850 Administration of levodopa and carbidopa |
| 07/28/2005 | US20050163849 Compositions and dosage forms for enhanced absorption of iron |
| 07/28/2005 | US20050163848 complexed with transport moiety comprising a lauryl sulfate salt; complex provides an enhanced absorption of the drug in the lower gastrointestinal tract; to control seizures or neuropathic pain with once daily administration |
| 07/28/2005 | US20050163841 to controllably deliver orally a drug at a substantially zero order delivery rate a during a window; improved oral absorption |
| 07/27/2005 | EP1254075A4 Nonaborate compositions and their preparation |
| 07/21/2005 | WO2005039494A3 Inhibitors of rnase p proteins as antibacterial compounds |
| 07/21/2005 | US20050159600 Crystalline R-guanidines, arginine or (L)-arginine (2S)-2-ethoxy-3-{4-[2-(10H-phenoxazin-10-yl)ethoxy]phenyl}propanoate |
| 07/21/2005 | US20050159457 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors |
| 07/21/2005 | US20050158374 Compositions and dosage forms for enhanced absorption of metformin |
| 07/21/2005 | US20050155862 guanidine and carboxyalkyl substituted polyalkylene polyamines with high isoelectric points; isoelectric focusing of proteins |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | CN1211358C Precipitation process of extracting arginine |
| 07/19/2005 | US6919036 Reacting borate with guanidinium or imidazolidinium compound; heating; crystal structure; forming ceramic; fire retarders, microbiocide |
| 07/13/2005 | CN1210256C Diacylhydrazine derivs |
| 07/12/2005 | US6916958 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 06/28/2005 | US6911470 Used in treatment of infection by retroviruses such as HIV (HTLV-III/LAV), which causes acquired immuno-deficiency syndrome (AIDS) |
| 06/28/2005 | US6911457 Diabetes imaging probes |
| 06/23/2005 | US20050137246 Organic amine salts of glutamic acid derivatives and their application |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/22/2005 | CN1629138A Process for preparing n-dodecylguanidineacetate |
| 06/22/2005 | CN1207279C Method of producing N-alkyl-N'-nitroguanidine |
| 06/21/2005 | US6908911 Antibacterial agents |
| 06/16/2005 | WO2005037798A3 Amide or thiomide derivatives and their use in the treatment of pain |
| 06/15/2005 | EP1539962A1 Polyene polyketides and methods of production |
| 06/15/2005 | CN1206211C Process for synthesis of medical biodegradable material in presence of bionic organic guanidine salt catalyst |
| 06/09/2005 | WO2005051296A2 Fused ring dicationic anti-protozoan agents and their prodrugs |
| 06/09/2005 | US20050124700 uses the strong antimicrobial properties of polymeric biguanides and the low cytotoxicity profile of polymeric quaternary ammonium compounds |
| 06/09/2005 | US20050124069 Transfection reagents |
| 06/09/2005 | CA2547972A1 Fused ring dicationic anti-protozoan agents and their prodrugs |
| 06/08/2005 | EP0849256B1 Amide compounds and use of the same |
| 06/08/2005 | CN1205191C Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 06/02/2005 | WO2004094457A3 Stable rgd peptidomimetic composition |
| 06/02/2005 | US20050119348 arylguanidine derivatives, for example N-[4-(2,3-bis-Bocguanidino)benzyl]2-(benzyl-oxycarbonyl)-2-phenylaceataride, N-(4-guanidinobenzyl) 2-(benzyloxycarbonyl)-2-phenylacetamide hydrochloride; antimetastasis agents |
| 06/02/2005 | US20050119245 Alpha -, beta -, and gamma -amino acid derivatives, e.g., S)-2-{N'-[4-(4-Fluoro-phenoxy)-phenyl]-N''-cyano-guanidino}-3-phenyl-N-(3-pyrrolidin-1-yl-propyl)-propionamide for the treatment of central nervous system conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain. |
| 06/01/2005 | CN1622953A Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 05/31/2005 | US6900231 Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/25/2005 | EP1533355A1 Ultraviolet-absorbing composition |
| 05/25/2005 | EP1533300A1 Organic amine salts of glutamic acid derivatives and their application |
| 05/25/2005 | CN1620426A Method for producing quaternary salt phenolate solutions and for regenerating and recycling quaternary salt phenolate solutions from reaction mixtures |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620337A Method for separating reaction mixtures and recycling of quaternary salts and bases |
| 05/25/2005 | CN1203055C Method and composition for treating or preventing bacterial infection |
| 05/24/2005 | US6897334 Production of creatine esters using in situ acid production |
| 05/21/2005 | CA2486838A1 Organic amine salts of glutamic acid derivatives and their application |
| 05/19/2005 | WO2005044810A1 Glyt2 modulators |
| 05/19/2005 | WO2005044787A1 Phenetanolamine derivatives |